“Funds will be used to accelerate regulatory activities, clinical and non-clinical development, and manufacture of drug toadvance ATH434 following recent release of its positive Phase 2 results in MSA. Funds will also be used to commence abusiness development process for potential partnering and to continue research and discovery of novel compounds totreat major indications such as Parkinson’s disease.”
Hope this helps to relieve frustration Looking 1 pip reduction at .011c
Money in the Bank$$ Big Pharma don’t mind paying a premium for a successful Phase 2 with $$$ in the Bank
ATH Price at posting:
1.2¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)